i9 Sports Presents the Chronicles of Narnia

Brandon, FL (May 15, 2008) The reviews are in and i9 Sport’s premier of The Chronicles of Narnia: Prince Caspian was a hit. Wednesday night, more than 170 fans including friends, family and staff of i9 Sports and Pediatric Cancer Foundation enjoyed a sneak preview of the Walt Disney Pictures’ film. It is scheduled to release on Friday, May 16.

“The Chronicles of Narnia: Prince Caspian was a fascinating film. My whole family really enjoyed it,” commented i9 Sports Founder and CEO Frank Fiume. Fiume and his family attended the movie premiere event in New York City earlier this month.

i9 Sports donated more than 50 Tampa Bay premiere tickets to the Pediatric Cancer Foundation. “The event gave our families a night away from the reality they live everyday. i9 Sports gave them a well-deserved break,” expressed Lisa Andrews, Development Director for the Pediatric Cancer Foundation.

i9 Sports Corporation, a leading franchisor of youth sports leagues, camps, and programs, announced a brand new collaboration with entertainment icon, Walt Disney Pictures. Entitled The Ticket to Narnia, this special promotion from i9 Sports offers parents who register their children for the upcoming i9 Sports season the chance to receive free tickets to the new action adventure from Walt Disney Pictures and Walden Media.

The Pediatric Cancer Foundation has funded more than $3.4 million to researchers at St. Joseph's Children's Hospital and H. Lee Moffitt Cancer Center & Research Institute in Tampa, All Children's Research Institute in St. Petersburg, the University of Florida in Gainesville, and the University of Miami School of Medicine.

Most recently, the Foundation launched The Sunshine Project – a novel collaborative research program which is fast-tracking the development of much needed new drugs and therapies that will lead to the cure of childhood cancers.  The Sunshine Project employs researchers from the country’s top institutions to significantly improve the survival rate of pediatric sarcoma patients within three years.

[back to news]